- Insuline Medical Ltd. is a Public Israeli company (TASE – INSL) focused on improving the performance of current insulin treatment methods, by trying to better approximate human physiology.
- Even with today’s rapid acting insulin analogs, there is a gap of at least one hour between bolus insulin injection and its peak in the blood system.
- Our solutions are disposable devices which treat with heat the point of injection, in order to improve and stabilize blood perfusion. It can be integrated into catheters used with insulin pumps, or as a stand alone disposable compatible with syringe or pen delivery.
- Unique technology - Disposable Devices instead of new drug – while having a relatively low risk and short device regulatory the market potential is of a new drug
- Promising clinical results – Extensive studies showed positive clinical results on diabetics, more studies are underway
- Real Need for Patients, Physicians and Payers – clinical data indicates that the devices can assist patients achieving better glycemic control, reduce complications and overall treatment costs
Insuline Medical is proud to launch a new corporate website and investor relations section.
The advanced site is home for all things related to Insuline - including information, reports, press releases, presentations, a smart search bar, connectivity to social services and much much more
